LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living ...

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in ...

The company notes that the workforce reduction is expected to provide annual cash compensation cost savings of approximately $15 million and offsets additional expenses expected based on the ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...

New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...

A new study demonstrates that handheld nanopore sequencers can rapidly identify eye infection pathogens using only a ...

In addition to Prevent Blindness’s usual free resources, the organization is providing a dedicated webpage, fact sheets, and ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...